Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Colorectal Adenoma: early-phase trial registry

4 of 9 indexed Colorectal Adenoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Colorectal Adenoma: 9 US clinical trials tracked, 4 recruiting.

Colorectal Adenoma is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 2 of these trials.

Enrollment posture brief

Registry condition colorectal-adenoma

OPEN 4 | RECR 44% | LATE 1 | EARLY 6 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Colorectal Adenoma (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Colorectal Adenoma

Colorectal Adenoma lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Colorectal Adenoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Colorectal Adenoma is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Colorectal Adenoma research.

    National Cancer Institute (NCI) accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Colorectal Adenoma enrolment sits around 110 participants.

    Median target enrolment is 110 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Colorectal Adenoma research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 25Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 5
Phase 3 1

Named interventions

Most-linked intervention names on Colorectal Adenoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Celecoxib Drug
2 trials
Linaclotide Drug
1 trials
Rectal Biopsy Procedure
1 trials
MUC1 Peptide-Poly-ICLC Vaccine Biological
1 trials
Placebo Administration Other
1 trials
Colonoscopy Diagnostic test
1 trials
FIT Diagnostic test
1 trials
Endoscopic submucosal dissection using the ELS System Device
1 trials

US sites by state

Facility locations filed on Colorectal Adenoma trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Massachusetts 3 trials
Virginia 2 trials
Texas 2 trials
Oregon 2 trials
Illinois 2 trials
Florida 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Colorectal Adenoma page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colorectal Adenoma condition card totals 9 registered trials; most-linked intervention Celecoxib; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.